The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related Cardiac Toxicity
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Cardiotoxicity Induced by Drug Therapy for Breast Cancer
Interventions: DRUG: Shengmai San (ingredients include ginseng, Ophiopogon japonicus, and Schisandra chinensis)
Sponsor: Zhejiang Cancer Hospital